Pacific Shuanglin Bio pharmacy Co Ltd (000403) — Cash Flow Reinvestment Rate
Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a Cash Flow Reinvestment Rate of 1.03x as of September 2025, reinvesting CN¥72.17 Million (capex CN¥72.17 Million ) from operating cash flow of CN¥70.28 Million. See Pacific Shuanglin Bio pharmacy Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pacific Shuanglin Bio pharmacy Co Ltd Cash Flow Reinvestment Rate (2000–2024)
Historical reinvestment intensity for Pacific Shuanglin Bio pharmacy Co Ltd across 21 annual periods. For the full cash flow conversion analysis, see 000403 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Pacific Shuanglin Bio pharmacy Co Ltd (2000–2024)
Year-by-year capital reinvestment analysis for Pacific Shuanglin Bio pharmacy Co Ltd. See 000403 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.11x | CN¥679.47 Million | CN¥321.79 Million | CN¥520.71 Million | ▲ +115.1% |
| 2023 | 0.98x | CN¥666.48 Million | CN¥679.01 Million | CN¥377.27 Million | ▼ -18.1% |
| 2022 | 1.20x | CN¥628.64 Million | CN¥524.22 Million | CN¥378.64 Million | ▲ +1.5% |
| 2021 | 1.18x | CN¥482.46 Million | CN¥408.22 Million | CN¥326.16 Million | ▲ +17.2% |
| 2020 | 1.01x | CN¥196.48 Million | CN¥194.84 Million | CN¥40.18 Million | ▼ -2.5% |
| 2019 | 1.03x | CN¥197.41 Million | CN¥190.84 Million | CN¥41.11 Million | ▲ +201.5% |
| 2018 | 0.34x | CN¥40.02 Million | CN¥116.63 Million | CN¥35.02 Million | ▼ -91.4% |
| 2016 | 3.98x | CN¥248.83 Million | CN¥62.49 Million | CN¥98.03 Million | ▲ +334.8% |
| 2015 | 0.92x | CN¥64.39 Million | CN¥70.31 Million | CN¥59.39 Million | ▼ -0.7% |
| 2014 | 0.92x | CN¥71.05 Million | CN¥77.04 Million | CN¥71.05 Million | ▼ -48.5% |
| 2013 | 1.79x | CN¥162.99 Million | CN¥91.01 Million | CN¥162.99 Million | ▲ +22.4% |
| 2012 | 1.46x | CN¥180.28 Million | CN¥123.24 Million | CN¥180.28 Million | ▲ +158.7% |
| 2011 | 0.57x | CN¥73.58 Million | CN¥130.14 Million | CN¥73.58 Million | ▼ -84.7% |
| 2010 | 3.69x | CN¥36.46 Million | CN¥9.88 Million | CN¥36.46 Million | ▲ +487.4% |
| 2009 | 0.63x | CN¥70.29 Million | CN¥111.86 Million | CN¥70.29 Million | ▲ +8.0% |
| 2008 | 0.58x | CN¥43.59 Million | CN¥74.90 Million | CN¥43.59 Million | ▲ +776.6% |
| 2007 | 0.07x | CN¥6.31 Million | CN¥95.03 Million | CN¥6.31 Million | ▼ -53.2% |
| 2005 | 0.14x | CN¥6.95 Million | CN¥49.06 Million | CN¥6.95 Million | ▼ -74.7% |
| 2002 | 0.56x | CN¥89.09 Million | CN¥159.18 Million | CN¥89.09 Million | ▼ -29.2% |
| 2001 | 0.79x | CN¥87.96 Million | CN¥111.28 Million | CN¥87.96 Million | ▼ -61.8% |
| 2000 | 2.07x | CN¥56.62 Million | CN¥27.36 Million | CN¥56.62 Million | — |